研选同类产品更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 用户评价
- 文献和实验
- 技术资料
- 抗体名:
CD133 antibody
- 抗体英文名:
CD133 antibody
- 靶点:
CD133. Human;Mouse;Rat. No cross reactivity with other proteins.
- 浓度:
- 100 μg (in 100 μl): 1 mg/ml- 200 μg (in 200 μl): 1 mg/ml
- 应用范围:
ELISA, ICC, IF, IHC-P, WB
- 宿主:
Rabbit
- 适应物种:
Human, Mouse, Rat
- 保质期:
6-12个月
- 抗原来源:
详询
- 目录编号:
orb99113
- 级别:
科研
- 库存:
99
- 供应商:
Biorbyt
- 标记物:
Unconjugated
- 克隆性:
Polyclonal
- 保存条件:
低温
- 形态:
10 mM PBS, 0.02% sodium azide, 10 mg/ml rAlbumin
- 亚型:
IgG
- 免疫原:
KLH conjugated synthetic peptide derived from human CD133. Please contact us for the exact immunogen sequence. The peptide is available as orb374954.
- 规格:
100 ug
产品名:CD133 antibody
货号:orb99113
产品中文名:CD133 抗体
IHC-P analysis of human muscle tissue using CD133 antibody (Primary antibody diluted to 1:100)
Immunohistochemical analysis of formalin-fixed and paraffin embedded human colonic adenocarcinoma tissue using CD133 antibody (Dilution of primary antibody 1:100)
Immunohistochemical analysis of paraffin-embedded human mammary cancer tissue using CD133 antibody
Immunofluorescent analysis of mouse brain tissue using CD133 antibody (Primary antibody diluted to 1:200)
一. 抗体(antibody):24万种的一抗。 可应用于Western blot,IP,IHC,IF,FACS,ELISA等实验。
二. 蛋白(protien):3.6万种的高纯度蛋白 。
三. elisa试剂盒(elisa kit):可以提 供超过1.5万种的ELISA试剂盒,包括人源,大鼠源,小鼠源等。
四. 小分子(Small Molecules):超过 1.5万种的生物活性小分子,主要包括:拮抗剂、抑制剂、抗生素、天然产物。
所有biorbyt品牌的抗体,蛋白,elisa试剂 盒,小分子等产品国际航空低温运输,货期短,多数产品货期在1~两周,快捷 便利。
我们为研究者们提供免费的专业的售前售中 售后服务,为您的实验保驾护航。
公司对外诚接特色技术外包服务如下:
重组蛋白表达与纯化服务、单克隆抗体定制 服务、多克隆抗体定制服务、免疫学检测服务、动物实验技术服务。我们为客户 提供详实的生物信息咨询和全方位的可行性分析方案,为您的科研项目保驾护航 。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
用户评价
暂无用户评价
文献和实验- Liao, C. H. et al. Restoration of erectile function with intracavernous injections of endothelial progenitor cells after bilateral cavernous nerve injury in rats Andrology, 3, 924-932 (2015)
- Jensen, Todd et al. Descriptive analysis of tumor cells with stem like phenotypes in metastatic and benign adrenal tumors J Pediatr Surg, 50, 1493-1501 (2015)
- Sun, Zhonghai et al. Tumour stem cell markers CD133 and CD44 are useful prognostic factors after surgical resection of pancreatic neuroendocrine tumours Oncol Lett, 20, 341 (2020)
- Nel, Ivonne et al. Circulating Tumor Cell Composition in Renal Cell Carcinoma PLoS One, 11, e0153018 (2016)
- Tu, Zhenbo et al. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer Int J Oncol, 50, 505-514 (2017)
- Nadal, Rosa et al. CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy Int J Cancer, 133, 2398-2407 (2013)
- Zhu, Yifan et al. Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells Exp Cell Res, 324, 146-156 (2014)
- Yang, Meng-Yin et al. An innovative three-dimensional gelatin foam culture system for improved study of glioblastoma stem cell behavior J Biomed Mater Res B Appl Biomater, 103, 618-628 (2015)
- Coni, Pierpaolo et al. Exploring cell surface markers and cell-cell interactions of human breast milk stem cells J Public Health Res, 12, (2023)
- Zou, Yuhong et al. Nrf2 is involved in maintaining hepatocyte identity during liver regeneration PLoS One, 9, e107423 (2014)
- Nowacki, Maciej et al. Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis Oncotarget, 6, 22776-22798 (2015)
- Hirashima, Kanji et al. Cell biological profiling of reprogrammed cancer stem cell-like colon cancer cells maintained in culture Cell Tissue Res, 375, 697-707 (2019)
- Kase, Marju et al. Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme Radiol Oncol, 47, 405-410 (2013)
- Feitosa, Neli Patrícia Pereira et al. Cancerous and non-neoplastic stem cells in the stomach similarly express CD44 and CD133 Acta Histochem, 123, 151787 (2021)
- Chen, Jintao et al. Proteomic Distributions in CD34+ Microvascular Niche Patterns of Glioblastoma J Histochem Cytochem, (2021)
- Winardi, Daniel et al. Correlation of altered expression of the autophagy marker LC3B with poor prognosis in astrocytoma Biomed Res Int, 2014, 723176 (2014)
- Feng, Long et al. Isolation and phenotypic characterization of cancer stem-like side population cells in colon cancer Mol Med Rep, 12, 3531-3536 (2015)
Prospective Identification of Cancer Stem Cells with the Surface Antigen CD133
Cancer cells do not share equal tumor-initiating potential. Only cancer stem cells (CSCs) can initiate cancer, which is important clinically because they should be eradicated to treat cancer patients. The purpose of experimental methods
Induced Pluripotent Stem Cells (iPSC) from Cord Blood CD133+ Cells Using Oct4 and Sox2
fibroblasts and keratinocytes, neural stem cells, hepatocytes, and blood cells, it is still under debate on what is the best source for generating iPSCs. In this chapter, we discuss how to generate human iPSCs from cord blood (CB) CD133+ cells using
combining with marker CD133 was used to detect the purity of FLSPCs and evaluate the isolating effects of the three-step method.










